• I progressi della ricerca sono l'unica speranza dei pazienti!


  • Sostenete la ricerca sulle malattie genetiche muscolari!


MDA clinical and scientific conference

Dallas, USA, 19-22 March 2023

Abstract submission open



26. Kongress des Medizinisch-Wissenschaftlichen Beirates der DGM

Essen, 22-25 March 2023

This meeting will be in german.

Info and deadlines


7th TREAT-NMD International Conference

Vancouver, Canada, 7-9 December 2022

Progress and lessons learned in the area of translational medicine in inherited neuromuscular diseases.

Abstracts submission extended until September 23rd


14. Neuromuskuläres Symposium

24. November 2022, Universitäts-Kinderspital Zürich, hybrid

Schwerpunkte des Symposiums: neue Gentherapien, Myositis. 

Programm und Anmeldung


19th IIM Meeting

Assisi, Italy, 20-23 October 2022

The Interuniversity Institute of Myology holds its 19th meeting, an invaluable opportunity to discuss scientific issues in the field of myology. Dedicated Advanced Myology training session reserved for trainees under 35 years.

Registration and abstracts extended until September 30th


33rd international symposium on ALS/MND

Virtual, 6-9 December 2022

The biggest annual conference dedicated to ALS and MND research brings together researchers from around the world to share new understanding of amyotrophic lateral sclerosis and motor neurone disease.

Registration open


Early Career Programme

Interested in participating in one of the upcoming ENMC workshops? If you are a young scientist (up to 5 years from your PhD defense) you may be eligible for a free participation.

List of upcoming ENMC workshops
Young Scientists Programme, conditions and guidelines


New papers


Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology.

Lathuiliere A, Vernet R, Charrier E, Urwyler M, Von Rohr O, Belkouch MC, Saingier V, Bouvarel T, Guillarme D, Engel A, Salmon P, Laumonier T, Grogg J, Mach N.
Mol Ther Methods Clin Dev. 2022 Aug...

12 agosto 2022

SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.

Lone MA, Aaltonen MJ, Zidell A, Pedro HF, Morales Saute JA, Mathew S, Mohassel P, Bonnemann CG, Shoubridge EA, Hornemann T.
J Clin Invest. 2022 Jul 28:e161908.

28 luglio 2022

Probing the Interactions of Splicing Regulatory Small Molecules and Proteins with U1 snRNP Using NMR Spectroscopy.

Campagne S, de Vries T, Allain FH.
Methods Mol Biol. 2022;2537:247-262.

22 luglio 2022

Serine Palmitoyltransferase Subunit 3 and Metabolic Diseases.

Lone MA, Bourquin F, Hornemann T.
Adv Exp Med Biol. 2022;1372:47-56

01 luglio 2022

Novel roles of mTORC2 in regulation of insulin secretion by actin filament remodeling.

Blandino-Rosano M, Scheys JO, Werneck-de-Castro JP, Louzada RA, Almaca J, Leibowitz G, Ruegg MA, Hall MN, Bernal-Mizrachi E.
Am J Physiol Endocrinol Metab. 2022 Jun 20.

20 giugno 2022

Pre-operative exercise and pyrexia as modifying factors in malignant hyperthermia (MH).

Riazi S, Bersselaar LRVD, Islander G, Heytens L, Snoeck MMJ, Bjorksten A, Gillies R, Dranitsaris G, Hellblom A, Treves S, Kunst G, Voermans NC, Jungbluth H.
Neuromuscul Disord. 2022 Jun...

11 giugno 2022

Development and early diagnosis of critical illness myopathy in COVID-19 associated acute respiratory distress syndrome

Rodriguez B, Branca M, Gutt-Will M, Roth M, Söll N, Nansoz S, Cameron DR, Tankisi H, Tan SV, Bostock H, Raabe A, Schefold JC, Jakob SM, Z'Graggen WJ.
J Cachexia Sarcopenia Muscle. 2022...

01 giugno 2022

Activation and Migration of Human Skeletal Muscle Stem Cells In Vitro Differently Rely on Calcium Signals.

Tollance A, Koenig S, Liaudet N, Frieden M.
Cells. 2022 May 19;11(10):1689.

19 maggio 2022

Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults.

Singh A, D'Amico D, Andreux PA, Fouassier AM, Blanco-Bose W, Evans M, Aebischer P, Auwerx J, Rinsch C.
Cell Rep Med. 2022 May 17;3(5):100633.

17 maggio 2022

Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland.

Tscherter A, Rüsch CT, Baumann D, Enzmann C, Hasselmann O, Jacquier D, Jung HH, Kruijshaar ME, Kuehni CE, Neuwirth C, Stettner GM, Klein A; Swiss-Reg-NMD group.
Neuromuscul Disord. 2022...

05 maggio 2022